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Abstract 
Acute stroke and transient ischaemic attack (TIA) are focal neurological syndromes of vascular origin and 
should be treated as medical emergencies. Brain imaging with computed tomography or magnetic 
resonance imaging is required to distinguish ischaemic stroke from intracerebral haemorrhage, recognize 
non-stroke pathologies that mimic stroke and guide investigation into the underlying mechanism. Acute 
interventions of benefit in ischaemic stroke include intravenous thrombolysis with alteplase given within 
4.5 hours of onset, endovascular thrombectomy within 6 hours of onset in selected patients, stroke unit 
care and aspirin. Decompressive hemicraniectomy reduces mortality in ischaemic stroke complicated by 
severe brain swelling. Intracerebral haemorrhage accounts for 10–15% of strokes, and while specific 
treatments are lacking at present, patients benefit from general measures, notably stroke unit care. TIA 
carries a high short-term risk of stroke, and immediate investigation and institution of secondary 
preventive treatment prevents a high proportion of this. Secondary prevention for ischaemic stroke and 
TIA should be tailored according to mechanism in individual patients. 
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Key points 
• Acute ischaemic stroke is common and disabling 
• Stroke unit care improves outcome, and all patients should be admitted to a specialist stroke 
service  
• Prompt recognition of stroke requires awareness of clinical patterns and radiological features 
• Treatment with intravenous thrombolytic drugs within 4.5 hours improves the odds of disability-
free recovery; the earlier treatment is initiated, the greater the effect 
• Additional endovascular mechanical thrombectomy using stent retrievers is highly effective in 
selected patients with occlusions of the intracranial internal carotid or middle cerebral artery 
• In minor ischaemic stroke and transient ischaemic attack, early institution of secondary 
prevention reduces the incidence of recurrent stroke  
• Intracerebral haemorrhage currently lacks evidence-based treatments beyond stroke unit care, 
but platelet transfusion is not helpful in antiplatelet-associated intracerebral haemorrhage  
 
 
Definition 
Stroke is a clinical syndrome defined by an acute focal neurological deficit with a vascular basis. Around 
85–90% of strokes are ischaemic (caused by arterial occlusion), and 10–15% result from intracerebral 
haemorrhage (ICH). The 1976 World Health Organization definition also includes subarachnoid 
haemorrhage, but this is primarily of epidemiological interest. The term ‘transient ischaemic attack’ (TIA) 
conventionally denotes complete resolution of all symptoms within 24 hours, but this arbitrary time limit is 
probably an anachronism in light of modern imaging and reperfusion treatment. 
 
Epidemiology 
Stroke incidence increases with age, although a quarter occur in patients <65 years of age. Causes vary 
by age group. Ischaemic stroke is the most common, with TIA next and ICH least common. There are 
approximately 150,000 incident strokes annually in the UK, and globally stroke is the third most common 
cause of death and most common disabling neurological disease. 
 
Risk factors 
Major predisposing factors for ICH and acute ischaemic stroke (AIS) are listed in Table 1. It is important to 
investigate the underlying mechanism in most individuals, regardless of risk factors. 
 
Diagnosis and natural history 
Presentations of AIS and ICH are similar, and the two cannot be distinguished without brain imaging. 
Symptoms are of sudden onset and usually maximal in severity at, or within minutes of, onset. Evolution 
of new neurological deficits or reduced level of consciousness is uncommon within the first few hours, but 
some deficits, notably lacunar strokes (‘capsular warning syndrome’) and incipient carotid occlusion, can 
fluctuate dramatically in severity. 
Symptoms of TIA are identical to those of ischaemic stroke but can include transient monocular 
blindness. TIA is distinguished only by complete resolution, typically within 30–60 minutes: the longer the 
symptoms last, the higher the probability of brain infarction (30% of TIAs resolving within 24 hours have 
infarcts on diffusion-weighted magnetic resonance imaging (MRI) – DWI). 
 
Clinical features 
Common clinical patterns are summarized by the Oxfordshire Community Stroke Project (OCSP) 
classification (Figure 1). A more detailed approach to relevant clinical examination is provided by the 
National Institutes of Health Stroke Scale (NIHSS; Table 2), for which online training is available. 
Contralateral hemiparesis can involve face, arm and leg equally (internal capsule, corticospinal 
tract) or be more focal (motor cortex), often face- and arm-predominant (typical of the distal middle 
cerebral artery (MCA) cortical territory) (Figure 2). Hemisensory disturbance is similarly distributed. 
Severity of weakness is not a reliable indication of stroke severity or prognosis: the presence of other 
neurological deficits and pattern of weakness are of more relevance. 
Conjugate gaze deviation (away from the affected limbs) results from involvement of the frontal 
eye field, a bilaterally represented centre that directs voluntary gaze. Often incorrectly attributed to 
visuospatial ‘neglect’, this usually resolves over days. Occasionally, pontine lesions cause gaze deviation 
towards the affected side. 
Higher cortical dysfunction is represented by language disorders (dysphasia) in dominant (usually 
left) hemisphere strokes, or visuospatial neglect, usually in non-dominant (right) hemisphere strokes. 
Dysphasia can conform to Broca's syndrome (characterized by non-fluent speech, recognized to be 
difficult and generally frustrating for the patient, with words omitted or substituted) or Wernicke's 
syndrome (fluent speech of abnormal content including word or phonemic substitution, the patient 
generally appearing unconcerned or unaware of the problem); the pattern is, however, often mixed. 
Broca's pattern dysphasia is usually accompanied by brachiofacial weakness because the relevant brain 
regions are anatomically close, whereas Wernicke-pattern dysphasia is usually not accompanied by 
motor deficits, and thus can be incorrectly described as ‘confusion’. Visuospatial neglect is identified by a 
failure to recognize bilateral simultaneous tactile or visual stimuli when a unilateral stimulus is perceived, 
and can also manifest as an apraxia of eye opening, unawareness of the neurological deficit 
(anosognosia) and inability to recognize the affected side. 
Contralateral homonymous hemianopia can occur in MCA strokes involving the optic radiation or 
in isolation with posterior cerebral artery strokes, when late presentation is common because the deficit is 
commonly asymptomatic or non-specific. Transient monocular blindness is a symptom of retinal 
ischaemia in ocular TIA. 
 
Differential diagnosis 
Common stroke mimics include: 
• intercurrent illness including infection, particularly in the elderly 
• hypoglycaemia 
•migraine aura 
•focal seizure or post-ictal state (Todd's paresis) 
•brain tumours 
•subdural haematoma 
•metabolic disturbance (including hypoxia and drug overdose) 
•hypotension. 
Reduced conscious level is the most important predictor of non-stroke pathology. Stroke rarely 
causes reduction of conscious level in the first few hours, exceptions being rapidly expanding 
supratentorial ICH or bilateral thalamic ischaemia (‘top of the basilar’ syndrome). In occlusion of the 
basilar artery (the main blood supply to the brainstem), a patient can be ‘locked in’ rather than truly 
unconscious. The Glasgow Coma Scale may not accurately reflect level of consciousness in acute stroke 
because of confounding by dysphasia in dominant hemisphere stroke, and apraxia of eye opening in non-
dominant hemisphere stroke. Reduced consciousness in ischaemic stroke otherwise typically occurs 2–5 
days after onset with large infarcts as a result of brain swelling (‘malignant MCA syndrome’). 
In someone with previous stroke, decompensation of an existing deficit can be caused by 
intercurrent illness, alcohol or sedative medication, stress or infection. 
 
Prognosis 
Outcome of acute stroke is predicted most strongly by the severity of the initial stroke (NIHSS score), 
together with age and blood glucose concentration. Compared with ischaemic stroke, ICH carries higher 
mortality (50% by day 30, compared with 17%). Outcome is a function of haematoma volume and is 
worse with early expansion and intraventricular extension of bleeding. 
Urgent evaluation of TIA is required as the 30-day stroke risk is around 10%, mainly within the 
first 7 days. Prognostic scores based on duration, symptoms, age and premorbid conditions can help risk 
stratification, and imaging findings including the presence of recent brain ischaemia on diffusion-weighted 
MRI, intracranial vessel occlusion and extracranial carotid stenosis also predict individuals at highest risk 
of early stroke.  
 
Immediate investigation 
Because acute reperfusion treatment is critically time-dependent, clinical assessment in acute stroke 
presenting within a potential time window for treatment should be focused and include only key 
information to inform treatment decisions. Blood pressure, NIHSS, history to define the time last known to 
be well (corroborated by witnesses if possible) and relevant medical history (other illnesses, medication 
history) are required. Minimum laboratory tests include blood glucose, platelet count and coagulation 
screen. 
 
Brain imaging 
Imaging is required to confirm the diagnosis and gives insight into mechanism and prognosis. Computed 
tomography (CT) is sensitive and specific for acute ICH (high attenuation on unenhanced CT).  
In AIS of moderate severity, CT has around 66% sensitivity in the first 5 hours after onset, but radiological 
signs are subtle. Typical changes associated with acute MCA occlusion are illustrated (Figure 3). Training 
and a systematic approach to CT review improve recognition. 
Patient selection for endovascular thrombectomy requires additional vascular imaging – usually 
CT angiography – to confirm the presence of large artery occlusion of relevant target intracranial vessels 
(ICA or M1 segment of MCA), adequate vascular access via the extracranial vessels and the status of 
intracranial leptomeningeal collateral vessels. The extent of any hypodensity on initial CT should be 
carefully reviewed because benefit of endovascular treatment is not clearly established in very extensive 
ischaemia. CT perfusion imaging may provide additional selection value and has been used in several 
recent trials. 
MRI offers improved sensitivity for both acute ischaemia and chronic haemorrhage compared 
with CT, but acquisition times are longer and MRI has more contraindications. DWI is highly sensitive to 
acute ischaemia and is more sensitive than CT for small lesions associated with minor or transient 
deficits. Susceptibility-weighted or gradient-echo MRI sequences are sensitive to haemoglobin 
degradation products and have similar sensitivity to CT for acute ICH; however, they also identify old 
haemorrhage, which cannot be distinguished from old ischaemic lesions by CT. The significance of small 
focal areas of old haemorrhage (cerebral microbleeds) on MRI is under investigation.  
 
Investigation for stroke mechanism 
Identifying the stroke mechanism is essential for optimal selection of secondary prevention. Initiation of 
secondary preventive treatment is urgent in many patients, particularly those with TIA or minor stroke 
where reperfusion therapy is not relevant. Most ischaemic strokes result from thromboembolism 
originating in the extracranial vessels or heart (Figure 4). Intracerebral small vessel disease can give rise 
to ischaemic strokes or ICH. Investigation should therefore include extracranial vascular imaging and 
cardiac rhythm monitoring, and in some cases intracranial vessel and heart imaging. ‘Embolic stroke of 
uncertain source’ is a proposed operational definition for strokes of embolic brain imaging appearances 
but lack of clear cardiac, extracranial or intracranial vascular disease. Subsequent investigation may 
identify paroxysmal atrial fibrillation in a proportion of patients initially in sinus rhythm. 
In ICH, haematoma location and patient age offer clues to the aetiology (Figure 4), but these 
associations overlap. Cerebral amyloid angiopathy (CAA) may give rise to repeated bleeding episodes. 
Arteriovenous malformation can underlie ICH, particularly in young or normotensive patients and may 
require intracranial vascular imaging.  
 
Treatment 
Stroke unit care benefits both ICH and AIS patients. Attendance to basic investigation and management 
(brain imaging, stroke unit admission, swallowing screening, aspirin prescription) improves outcomes 
and avoids complications.1 Very early aggressive mobilization is not beneficial,2 and early 
multidisciplinary team management is essential. Stroke patients are vulnerable to pneumonia, deep vein 
thrombosis, urinary tract infection, aspiration, depression, falls and shoulder subluxation; deterioration 
should therefore prompt a review for systemic causes. 
Intracerebral haemorrhage 
Neither haemostatic treatment nor aggressive blood-pressure-lowering has been established to improve 
outcome, and some trials are ongoing. Platelet transfusion in ICH among patients on antiplatelet therapy 
was associated with poorer outcome in a recent trial. Evidence for acute surgical interventions 
(evacuation via craniotomy, drainage via a burr hole or stereotaxy, external ventricular drainage of 
intraventricular blood) is limited. A strategy of ICH evacuation within 48 hours was no better than initial 
conservative management, but few studies have evaluated intervention within the first few hours, when 
deterioration usually occurs.  
 
Ischaemic stroke 
Intravenous thrombolysis with alteplase, a recombinant tissue plasminogen activator, improves the 
proportion of patients with complete neurological recovery when given within 4.5 hours of symptom onset. 
Earlier treatment is associated with greater likelihood of benefit.3 The number-needed-to-treat (NNT) for 
excellent recovery is 5 for patients treated within 90 minutes, 9 if treated within 91–180 minutes and 14 if 
treated within 191–270 minutes of onset. The absolute excess risk of ICH with significant neurological 
deterioration is related primarily to stroke severity and rises from 1.5% in very mild stroke to 3.7% in very 
severe stroke. There is a slightly higher early mortality with treatment, and it is important to consider the 
balance of risk and benefit in individuals; however, there is net benefit across almost all subgroups of age 
and severity.4 Treatment of 15–20% of AIS is possible, systems should be organized to minimize door-to-
needle times. Rapid assessment and scanning of all patients has general benefits. 
Intravenous alteplase recanalizes occluded arteries in around 56% of patients, and is least 
effective with the largest clots (and most severe strokes), with <10% recanalization in intracranial ICA 
occlusion. Endovascular mechanical thrombectomy improved clinical outcomes significantly in patients 
with ICA and MCA M1 segment occlusion in a series of recent trials. Pooled analysis of the five trials 
published in 20155 showed an absolute increase in disability-free survival of 19.5% (NNT 5).and NNT of 3 
to move upwards to a more favourable disability level. In 90% of cases in all trials, thrombectomy was 
undertaken in patients treated early with intravenous recombinant tissue plasminogen activator (rtPA) and 
in the setting of highly organized specialist services. Benefit of thrombectomy also declines steeply with 
time. Very few patients were randomized beyond 6 hours after onset, and reperfusion (i.e. the end of the 
procedure) beyond 7 hours was not beneficial. Relative treatment effects were consistent across major 
age groups and stroke severities. 
Decompressive hemicraniectomy reduces mortality in patients with ‘malignant’ brain swelling after 
a large infarction, but a high proportion of survivors remain disabled. 
Aspirin started within 48 hours (300 mg/day for up to 14 days) reduces death or dependence, 
probably acting as acute secondary prevention. If intravenous thrombolysis is given, aspirin should be 
withheld for 24 hours as it increases the risk of haemorrhage. 
 
 
Secondary prevention 
Preventive treatment should be informed by the mechanism of stroke in each individual, and can include 
antiplatelet, antihypertensive or anticoagulant therapy, statins and surgical carotid endarterectomy. 
In non-randomized comparisons, significantly fewer strokes occurred when secondary preventive 
treatments were started within 24 hours of symptoms in patients with TIA, compared with delayed 
institution of treatment.  
 
  
  
Major risk factors for stroke 
Modifiable Unmodifiable 
ICH 
Hypertension 
Alcohol excess 
Drug treatments – thrombolytic agents, 
anticoagulants, antiplatelet agents 
Diabetes mellitus 
Cigarette smoking 
Age 
Apolipoprotein E ɛ2 or ɛ4 carriage 
(CAA) 
Race (probably higher in South-East 
Asian populations) 
Ischaemic stroke 
Hypertension Age 
Diabetes mellitus (or elevated HbA1c) 
Ischaemic heart disease 
Atrial fibrillation 
Valvular heart disease 
Cigarette smoking 
Dietary Risks (high sodium, low fruit and vegetables) 
Low physical activity 
 
Table 1 
  
 
 
NIHSS items 
Item Score range 
•LOC 
– LOC questions 
– LOC commands 
0–3 
0–2 
0–2 
•Best gaze 0–2 
•Visual fields 0–3 
•Facial weakness 0–3 
•Motor, arm 0–4 (right and left) 
•Motor, leg 0–4 (right and left) 
•Limb ataxia 0–2 
•Sensory loss 0–2 
•Best language 0–3 
•Dysarthria 0–2 
•Extinction and inattention 0–2 
  
 Table 2 
LOC, level of consciousness. 
  
 
Figure 1 
OCSP classification: syndromes and imaging examples. 
ICA, internal carotid artery.  
  
 
Figure 2  
Anterior circulation vascular territories and major intracranial vessels. 
  
 
Figure 4  
ICH appearance, location and associations. 
 
 
Figure 3 
Early radiological features of AIS due to MCA M1 segment occlusion. 
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